Lovo
Automated Cell Processing System

PROCESS FAST. MAXIMIZE CONTROL.

Only Lovo delivers automated, functionally closed cell processing through spinning membrane filtration.

Designed with you in mind.

Hear the people behind Lovo talk about how its technology, design, and performance were driven from the needs of labs like yours.

Applications

Achieve
flexibility with a

single instrument.

Each cell therapy manufacturing process is unique. Lovo's flexibility supports multiple applications, at any stage of your operation.

Design

Count on a platform instrument that
scales with you.

Whether you're working with millions or billions of cells, in 10mL or 22L, Lovo adapts with you to easily scale your process, from Phase 1 through Commercialization.

Technology

Spinning membrane filtration is fast, adaptable, and non‑fouling.

You don't need to trade cell recovery with washout efficiency. Lovo’s spinning membrane filtration allows you to process a wide range of cell volumes and concentrations quickly, while maximizing recovery and cell viability.

Data Management

Access secure procedure data. Anytime, anywhere.

Lovo DXT allows for secure, wired or wireless data transfer. Generate reports, filter procedure records, and export directly to Microsoft Excel or your LIMS.

Joint Venture​

Cell therapy manufacturing that’s simple and scalable.

Cue seamlessly incorporates into the ScaleReady cell therapy manufacturing platform, enabling you to rapidly generate and package life-saving cell therapies at scale.

ScaleReady

Stay Informed.

Sign up below to receive the latest Lovo news and updates.

See Us In Action.

Come see what Lovo’s all about. We’ll walk you through the features and arrange a demo.

BioProcess International
September 20 - 23, 2021
Boston, MA

Cell & Gene Meeting on the Mesa
October 12 - 14, 2021
Carlsbad, CA

Document

Need more info?

Download it here.

Lovo Brochure | PDF

Fresenius Kabi Product Catalog | PDF

 

Immunomagnetic Selection Prep Diagram | PDF

The LOVO Cell Processing system is for laboratory use only. Unless the user has obtained advance clearance or approval from the appropriate regulatory agency, cells processed on this system are not intended for diagnostic purposes, direct transfusion, or for use in the production of therapeutic products or vaccines for clinical use. For applications requiring regulatory clearance or approval, users may request the required LOVO technical documentation from Fresenius Kabi to support their submissions.

Refer to the LOVO Cell Processing System Operator’s Manual for a complete list of warnings and precautions associated with the use of this device.

References

  1. LOVO 2.X Blood Run Protocol Report: 223-DER-048957 – Data on file at Fresenius Kabi USA.
  2. LOVO 2.X Product Quality Test Results Design Review: 223-DER-048958 – Data on file at Fresenius Kabi USA.
  3. Lovo New Membrane Cultured Cell Testing Results: 223-DER-066723 – Data on file at Fresenius Kabi USA.
  4. B.Mfarrej, et al. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts. Cytotherapy, Volume 19, Issue 12, 1501-1508.

About Fresenius Kabi USA

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.

Our products are used to help care for critically and chronically ill patients. The people of Fresenius Kabi are driven by a common purpose to put lifesaving medicines and technologies in the hands of people who care for patients, and to find answers to the challenges they face.